NCT06906653
Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
Enrolling by Invitation
NAAges 18–74InterventionalHealth servicesKaiser PermanenteInvestigator-initiated
~204 participants
Updated 2025-04-02 on ClinicalTrials.gov
What's tested:Augmented Initial Type 2 Diabetes Care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Average hemoglobin A1c (HbA1c)
Measured over 6-months
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18-74 years
Newly diagnosed with type 2 diabetes
Kaiser Permanente Northern California member receiving care in a participating service area
If age ≤45 years, then HbA1c\>8%
If age\<45 years, then HbA1c\>10%
Exclusion
Individuals who are pregnant
Individuals with likely type 1 diabetes (T1D)
What this trial measures
- Average hemoglobin A1c (HbA1c)6-months
Between-arm differences in HbA1c
- Average hemoglobin A1c (HbA1c)12-months
Between-arm differences in HbA1c